IHMD 2022 Successfully Concluded
The Third International High-End Medical Device Forum (IHMD 2022) were successfully concluded in Shanghai on Nov 4.
With the theme of “Value Innovation, Brand Rebuilding”, IHMD 2022 brought domestic and overseas enterprises focusing on high-quality device technology together, with many experts, scholars and industry leaders participated. Centering on the research and development of high-end medical devices as well as the trends and characteristics of manufacturing industry, IHMD 2022 had an in-depth discussion on the future development direction and prospects, and provided a comprehensive display of the most cutting-edge technology achievements and products.
IHMD 2022 – CCRC Booth
In this IHMD, CCRC received many visitors and industry professionals, with whom we had communicated medical device clinical research services, answered questions and provided professional suggestions for visitors who need CRO service by fully considering their actual needs. CCRC also prepared exquisite gifts for the visitors.
Exhibition Site – Sharing by CCRC General Manager
At the cardiovascular and cerebrovascular forum, Ms. Julia , the General Manager of CCRC, as an invited speaker, provided a wonderful sharing on “Considerations and Challenges on the Implementation of Multi-Regional Medical Device Clinical Trials” based on her rich working experience in CRO industry, which received overwhelming positive feedbacks from the audience.
Ms. Julia has more than 15 years of working experience in the field of new drug and medical device research and development, and she had worked in many well-known multinational pharmaceutical companies, medical device companies and CROs. Her team have participated in more than 100 medical device registration clinical trials in China and also assisted many local device companies in conducting relevant clinical trials and device registration in Europe and the USA.
According to Ms. Julia, the following aspects are important in meeting the challenges in conducting multi-regional device clinical trials,:
(1)The Standard of Care in the target country or region should be fully understood in the phase of protocol design.
(2)Reach out to the local regulatory authorities to proactively communicate on the preclinical and clinical preparations as soon as possible.
(3)Prepare an international talents and resources pool, and accept diverse cultures are conducive to the management and promotion of projects.
As a global CRO deeply engaged in medical device technology, CCRC has accumulated rich experience and professional teams for multinational clinical trial projects. We have helped many devices from local companies go overseas and overseas products enter China market, and accelerated the clinical research process of devices from many domestic and overseas enterprises and scientific research institutions.
Concluding Remarks
Many thanks for your attention and support! CCRC will continue to provide professional one-stop services in the full life cycle of clinical research and development in more medical device projects!
